You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-Niemann Pick C1 antibodySee all Niemann Pick C1 primary antibodies ...
  • Description
    Mouse monoclonal to Niemann Pick C1
  • Tested applicationsWB, ICC, IHC-P, ICC/IF, Flow Cyt more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant fragment: GFANAMYNAC RDVEAPSSND KALGLLCGKD ADACNATNWI EYMFNKDNGQ APFTITPVFS DFPVHGMEPM NNATKGCDES VDEVTAPCSC QDCSIVCGPK , corresponding to amino acids 151-250 of Human Niemann Pick C1

Applications

Our Abpromise guarantee covers the use of ab55706 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use a concentration of 1 - 5 µg/ml.
ICC ICC: Use at an assay dependent concentration.
IHC-P IHC-P: Use a concentration of 1 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
ICC/IF ICC/IF: 1/10.
Flow Cyt Flow Cyt: Use 1µg for 106 cells.

Target

  • FunctionInvolved in the intracellular trafficking of cholesterol. May play a role in vesicular trafficking in glia, a process that may be crucial for maintaining the structural and functional integrity of nerve terminals.
  • Involvement in diseaseDefects in NPC1 are the cause of Niemann-Pick disease type C1 (NPDC1) [MIM:257220]. A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C1 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood. An allelic variant of Niemann-Pick disease type C1 is found in people with Nova Scotia ancestry. Patients with the Nova Scotian clinical variant are less severely affected.
  • Sequence similaritiesBelongs to the patched family.
    Contains 1 SSD (sterol-sensing) domain.
  • DomainA cysteine-rich N-terminal domain and a C-terminal domain containing a di-leucine motif necessary for lysosomal targeting are critical for mobilization of cholesterol from lysosomes.
  • Post-translational
    modifications
    Glycosylated.
  • Cellular localizationLate endosome membrane. Lysosome membrane.
  • Target information above from: UniProt accession O15118 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      Niemann Pick C1 protein precursor antibodyNiemann Pick disease, type C1 antibodyNiemann-Pick C1 protein antibody
      NPC antibodyNPC1 antibodyNPC1_HUMAN antibody
    see all

Anti-Niemann Pick C1 antibody images

  • Western blot against tagged recombinant protein immunogen using ab55706 Niemann Pick C1 antibody at 1ug/ml. Predicted band size of immunogen is 34 kDa
  • ab55706 at 10 ug/ml staining Niemann Pick C1 in human A-431 cells by Immunocytochemistry/ Immunofluorescence.

  • IHC image of ab55706 staining in human normal liver formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab55706, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

    For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

  • Overlay histogram showing A431 cells stained with ab55706 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab55706, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

References for Anti-Niemann Pick C1 antibody (ab55706)

This product has been referenced in:
  • Field FJ  et al. TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. J Lipid Res 51:1407-15 (2010). Read more (PubMed: 20103810) »

See 1 Publication for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Immunocytochemistry
Sample Human Cultured Cells (macrophages)
Specification macrophages
Fixative Formaldehyde
Permeabilization Yes - Triton X-100
Blocking step BSA as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 1% · Temperature: 22°C
Username

Verified customer

Submitted Feb 16 2010

Application Western blot
Sample Human Cell lysate - whole cell (THP-1 cells)
Loading amount 30 µg
Specification THP-1 cells
Gel Running Conditions Reduced Denaturing (10%)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Nov 20 2009

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"